Rigel Pharma (RIGL) Misses Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $32.91 -1.38%
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Financial Fact:
Total costs and expenses: 26.5M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) reported Q1 EPS of ($0.40), $0.04 worse than the analyst estimate of ($0.36).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rigel Pharmaceuticals closes $70M VEPPANU license deal with ARVINAS and PFIZER
- CarMax (KMX) Tops Q1 EPS by 35c, Beats on Revenue
- Rigel Announces Closing of Licensing Agreement for VEPPANU™ (vepdegestrant)
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
